Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Bei Hu, MD, Tommy Chen, Danielle Boselli, MS, Rupali Bose, MS, MBA, James T. Symanowski, PhD, Derek Raghavan, MDPhDFACP,FRACP, Amy Soni, MD, Steven I Park, MD, Belinda R Avalos, MD, Edward A Copelan, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2019) 134 (Supplement_1): 425.

https://doi.org/10.1182/blood-2019-123998

Published: 2019

Journal Articles

Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

Christina M Barriteau, MD, Mariam Kayle, PhD RN, Joseph M Feinglass, PhD, Paige VonAchen, BA, Robert I Liem, MD MS, Sherif M. Badawy, MD, Kristin Kan, MDMPH,MSc

Blood (2019) 134 (Supplement_1): 2107.

https://doi.org/10.1182/blood-2019-128150

Published: 2019

Journal Articles

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Mónica Bustillos Muñoz, MD, Diana E Garcia-Camarillo, MD, Rosario Salazar Riojas, Chem., Leslie Silva López, Quem., Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2057.

https://doi.org/10.1182/blood-2019-131627

Published: 2019

Journal Articles

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Ivy Abraham, MD, Garth Rauscher, PhD MPH, Anand Ashwin Patel, MD, Wendy Stock, MD, Maryam Zia, MD, Sushma Bharadwaj, MD, Koosha Paydary, MD, Maria Acevedo-Mendez, John P Galvin, MDMS,MPH, William Pearse, MD, Jessica K. Altman, John G. Quigley, Priya Rajakumar, MD, Melissa L. Larson, MD, Irum Khan, MD

Blood (2019) 134 (Supplement_1): 3413.

https://doi.org/10.1182/blood-2019-124974

Published: 2019

Journal Articles

Early Mortality after Diagnosis of Diffuse Large B-Cell Lymphoma : A Retrospective, Single Urban-Community Hospital Study

Kunhwa Kim, MDMPH, Vinicius Machado Jorge, MD, Andrew Tiu, MD, Peter Mousaa, Sorab Gupta, MD, Djeneba Djibo, Claudia Dourado, MD

Blood (2019) 134 (Supplement_1): 5335.

https://doi.org/10.1182/blood-2019-132126

Published: 2019

Journal Articles

Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center Experience

Rebecca Krakora, BA, Weichung Shih, PhD, Pallvi Popli, MD, Elan Gorshein, DO, Gratian Salaru, MD, Kevin A. David, MD, Rajat Bannerji, MD PhD

Blood (2019) 134 (Supplement_1): 5071.

https://doi.org/10.1182/blood-2019-129390

Published: 2019

Journal Articles

Sociodemographic and Hospital Level Disparities in Palliative Care Utilization Among Terminally Ill Patients with Multiple Myeloma

Kahee A Mohammed, MD, Nosayaba Osazuwa-Peters, BDS, PhD MPH, Kristen M Sanfilippo, MD MPHS

Blood (2018) 132 (Supplement 1): 3594.

https://doi.org/10.1182/blood-2018-99-116147

Published: 2018

Journal Articles

Veterans Treated with R-CHOP for Diffuse Large B Cell Lymphoma Compared to Neighboring Hospital: An Interesting Discovery for Treatment Outcomes

Jessica Trevino Jones, MD, Manuel Ricardo Espinoza-Gutarra, MD, Sushanth Kakarla, MBBS, Michelle Janania Martinez, MD, David Gregorio, MD, Prathibha Surapaneni, Michael Mader, Zohra Nooruddin, MD

Blood (2018) 132 (Supplement 1): 3604.

https://doi.org/10.1182/blood-2018-99-119667

Published: 2018

Journal Articles

Nonbiological Factors Affecting Outcomes in Adolescent and Young Adults with Lymphoma

Ana C. Xavier, MD, Luciano J Costa, MD PhD

Blood (2018) 132 (Supplement 1): 4857.

https://doi.org/10.1182/blood-2018-99-115724

Published: 2018

Journal Articles

Impact of Insurance Status on Survival of Patients Diagnosed with Acute Promyelocytic Leukemia in the United States

Omer Jamy, MD, Ana C. Xavier, MD, Luciano J Costa, MD PhD

Blood (2018) 132 (Supplement 1): 321.

https://doi.org/10.1182/blood-2018-99-116125

Published: 2018

Journal Articles

Survival of Chronic Myeloid Leukemia Patients in Comparison to General Population in the Tyrosine Kinase Inhibitors Era: A US Population Based Study

Rehan Sarmad, MD MBBS, Omer Jamy, Luciano J. Costa, MD PhD

Blood (2017) 130 (Supplement 1): 2165.

https://doi.org/10.1182/blood.V130.Suppl_1.2165.2165

Published: 2017

Journal Articles

Risk of 30-Day Mortality and Its Association with Health System and Socioeconomic Factors in Diffuse Large B Cell Lymphoma (DLBCL)

Avyakta Kallam, MBBS, Julie M Vose, MD, Baojiang Chen, PhD, James O. Armitage, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 2347.

https://doi.org/10.1182/blood.V128.22.2347.2347

Published: 2016

Journal Articles

Racial/Ethnic and Socioeconomic Disparities in the Use of Autologous Hematopoietic Stem Cell Transplant (ASCT) Among Californians with Multiple Myeloma (MM)

Aaron S Rosenberg, MD MS, Ann M Brunson, MS, Joseph Tuscano, MD, Brian A Jonas, MD PhD, Ted Wun, MD, Theresa Keegan, PhD MS

Blood (2016) 128 (22): 846.

https://doi.org/10.1182/blood.V128.22.846.846

Published: 2016

Journal Articles

The Impact of Insurance Status at Diagnosis on Overall Survival in Chronic Myeloid Leukemia: A Population-Based Analysis

Ashley M. Perry, BS, Tao Zou, MD PhD, Andrew M. Brunner, MD, Donna S Neuberg, ScD, Amir T. Fathi, MD

Blood (2015) 126 (23): 631.

https://doi.org/10.1182/blood.V126.23.631.631

Published: 2015

Journal Articles

Insurance Status, Marital Status and Income, but Not Race-Ethnicity Affect Outcomes of Younger Patients Diagnosed with Multiple Myeloma in the US

Luciano J Costa, MD PhD, Elizabeth E. Brown, PhD MPH

Blood (2015) 126 (23): 633.

https://doi.org/10.1182/blood.V126.23.633.633

Published: 2015

Journal Articles

Acute Myelogenous Leukemia: Insurance Status, Race and Comorbidities, but Not Distance from Treatment Center Determine Outcome

Samip Master, MD, Zhenzhen Shi, Srinivas S. Devarakonda, MD, Reinhold Munker, MD, Runhua Shi, MDPhDMPH

Blood (2015) 126 (23): 3283.

https://doi.org/10.1182/blood.V126.23.3283.3283

Published: 2015

Journal Articles

Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

Bilal Ahmad, MD, Hossein Maymani, MD, Haseeb Saeed, MD, Mohamad Khawandanah, MD, Samer A Srour, MB ChB, Michael G Machiorlatti, MS, Adam S. Asch, MD, Mohamad Cherry, MD

Blood (2014) 124 (21): 2274.

https://doi.org/10.1182/blood.V124.21.2274.2274

Published: 2014

Journal Articles

Insurance Status Impacts Survival in Follicular Lymphoma

Loretta J. Nastoupil, MD, Xuesong Han, PhD, Ahmedin Jemal, DVM, PhD, Elizabeth Ward, PhD, Christopher R. Flowers, MD

Blood (2014) 124 (21): 1327.

https://doi.org/10.1182/blood.V124.21.1327.1327

Published: 2014

Journal Articles

Non-Biological Factors Affecting Survival in Younger Patients with Acute Myeloid Leukemia

Luciano J Costa, MD PhD, Uma M Borate, MD, Shin Mineishi, MD

Blood (2014) 124 (21): 1273.

https://doi.org/10.1182/blood.V124.21.1273.1273

Published: 2014

Journal Articles

The Effect Of Insurance Status and Comorbidities On Outcomes After Splenectomy Among Patients With ITP

Gaurav Kistangari, MD, Keith R. McCrae, MD, Swapna Thota, MD, Nicholas Schiltz, Siran M Koroukian, PhD

Blood (2013) 122 (21): 3560.

https://doi.org/10.1182/blood.V122.21.3560.3560

Published: 2013

NARROW

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML

Early Mortality after Diagnosis of Diffuse Large B-Cell Lymphoma : A Retrospective, Single Urban-Community Hospital Study

Impact of Insurance Status on Survival Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL): A Single Center Experience

Sociodemographic and Hospital Level Disparities in Palliative Care Utilization Among Terminally Ill Patients with Multiple Myeloma

Veterans Treated with R-CHOP for Diffuse Large B Cell Lymphoma Compared to Neighboring Hospital: An Interesting Discovery for Treatment Outcomes

Nonbiological Factors Affecting Outcomes in Adolescent and Young Adults with Lymphoma

Impact of Insurance Status on Survival of Patients Diagnosed with Acute Promyelocytic Leukemia in the United States

Survival of Chronic Myeloid Leukemia Patients in Comparison to General Population in the Tyrosine Kinase Inhibitors Era: A US Population Based Study

Risk of 30-Day Mortality and Its Association with Health System and Socioeconomic Factors in Diffuse Large B Cell Lymphoma (DLBCL)

Racial/Ethnic and Socioeconomic Disparities in the Use of Autologous Hematopoietic Stem Cell Transplant (ASCT) Among Californians with Multiple Myeloma (MM)

The Impact of Insurance Status at Diagnosis on Overall Survival in Chronic Myeloid Leukemia: A Population-Based Analysis

Insurance Status, Marital Status and Income, but Not Race-Ethnicity Affect Outcomes of Younger Patients Diagnosed with Multiple Myeloma in the US

Acute Myelogenous Leukemia: Insurance Status, Race and Comorbidities, but Not Distance from Treatment Center Determine Outcome

Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

Insurance Status Impacts Survival in Follicular Lymphoma

Non-Biological Factors Affecting Survival in Younger Patients with Acute Myeloid Leukemia

The Effect Of Insurance Status and Comorbidities On Outcomes After Splenectomy Among Patients With ITP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only